Leading UK role in the design and conduct of clinical trials in multiple sclerosis (includes: first gene therapy trial at the Sheffield Teaching Hospitals NSH Foundation Trust and the first phase III Autologous Haematopoietic Stem Cell Transplantation treatment in patients with multiple sclerosis).